Arterial and Venous Function in Hypertension

Comprehensive Hypertension

Volumn , Issue , 2007, Pages 205-212

  Thakali, Keshari M ^a   Galligan, James J ^a   Fink, Gregory D ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35548935497     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03961-1.50022-2     Document Type: Chapter

References (46)

1. HW Farber and J Loscalzo (2004) Pulmonary arterial hypertension. N Engl J Med 351 1655-1665.
2. VV McLaughlin and S Rich (2004) Pulmonary hypertension. Curr Probl Cardiol 29 575-634.
3. M Mela, A Mancuso and A Burroughs (2002) Drug treatment for portal hypertension. Ann Hepatol 1 102.
4. SJ Knechtle (2003) Portal hypertension: from Eck's fistula to TIPS. Ann Surg 238 S49-S55.
5. D Shin, G Garcia-Cardena, S Hayashi, et al. (2001) Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230 139-150.
6. AW Boyd and M Lackmann (11 December 2001) Signals from Eph and Ephrin proteins: A developmental tool kit. Science's STKE
7. DL Kreulen (2003) Properties of the venous and arterial innervation in the mesentery. J Smooth Muscle Res 39 269-279.
8. S Manzini, F Perretti, M Tramontana, et al. (1991) Neurochemical evidence of calcitonin gene related peptide-like immunoreactivity (CGRP-LI) release from capsaicin sensitive nerves in rat mesenteric arteries and veins. Gen Pharmacol 22 275-278.
9. N Toda and T Okamura (2003) The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 55 271-324.
10. F Amenta, C Cavallotti, F Dotta, et al. (1983) The autonomic innervation of the human greater saphenous vein. Acta Histochem 72 111-116.
11. F Brandao (1976) A comparative study of the role played by some inactivation pathways in the disposition of the transmitter in the rabbit aorta and the saphenous vein of the dog. Blood Vessels 13 309-318.
12. OD Hottenstein and DL Kreulen (1987) Comparison of the frequency dependence of venous and arterial responses to sympathetic nerve stimulation in guinea pigs. J Physiol 384 153-167.
13. KN Browning, ZL Zheng, DL Kreulen and RA Travagli (1999) Two populations of sympathetic neurons project selectively to mesenteric artery or vein. Am J Physiol 276 H1263-H1272.
14. M Luo, MC Hess, GD Fink, et al. (2003) Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats. Auton Neurosa 104 47-57.
15. RZ Zhang, Q Yang, APC Yim, et al. (2004) Different role of nitric oxide and endothelium-derived hyperpolarizing factor in endothelium-dependent hyperpolarization and relaxation in porcine coronary arterial and venous system. J Cardiovasc Pharmacol 43 839-850.
16. TJ Guzik, NEJ West, R Pillai, et al. (2002) Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 39 1088-1094.
17. MG de Sousa, JC Yugar-Toledo, M Rubira, et al. (2005) Ascorbic acid improves impaired venous and arterial endothelium dependent dilation in smokers. Acta Pharmacological Sínica 26 447-452.
18. AA Perez-Rivera, GD Fink and JJ Galligan (2004) Increased reactivity of murine mesenteric veins to adrenergic agonists: Functional evidence supporting increased α 1 -adrenoceptor reserve in veins compared with arteries. J Pharmacol Exp Ther 308 350-357.
19. CJ Leech and JE Faber (1996) Differential sensitivity of venular and arteriolar α-adrenergic receptor constriction to inhibition by hypoxia. Ore Res 78 1064-1074.
20. SW Watts, GD Fink, CA Northcott and JJ Galligan (2002) Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension: Studies with receptor agonists. Br J Pharmacol 137 69-79.
21. K Thakali, GD Fink and SW Watts (2004) Arteries and veins desensitize differently to endothelin. J Cardiovasc Pharmacol 43 387-393.
22. SM Dethlefsen, D Shepro and PA D'Amore (1996) Comparison of the effects of mechanical stimulation on venous and arterial smooth muscle cells in vitro. J Vase Res 33 405-413.
23. Z Yang, BS Oemar, T Carrel, et al. (1998) Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels. Circulation 97 181-187.
24. AP Wong, N Nili and BH Strauss (2005) In vitro differences between venous and arterial-derived smooth muscle cells: Potential modulatory role of decorin. Cardiovasc Res 65 702-710.
25. PN Waybill, VM Chinchilli and BJ Ballermann (1997) Smooth muscle cell proliferation in response to co-culture with venous and arterial endothelial cells. J Vase Interv Radiol 8 375-381.
26. G Ulrich-Merzenich, C Metzner, RR Bhonde, et al. (2002) Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins. In vitro Cell Dev Biol 38 265-272.
27. A Swei, F Lacy, FA DeLano and GW Schmid-Schonbein (1997) Oxidative stress in the Dahl hypertensive rat. Hypertension 30 1628-1633.
28. K Thakali, SL Demel, GD Fink and SW Watts (2005) Endothelin-1 (ET-1)-induced contraction in veins is independent of hydrogen peroxide (H 2O 2). Am J Physiol Heart Circ Physiol 289(3), H1115-H1122.
29. M Brinsuk, J Tank, FC Luft, et al. (2004) Heritability of venous function in humans. Arterioscler Thromb Vase Biol 24 207-211.
30. LD Adams, RL Geary, B McManus and SM Schwartz (2000) A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res 87 623-631.
31. J Zhou, K Moroi, M Nishiyama, et al. (2001) Characterization of RGS5 in regulation of G protein-coupled receptor signaling. Life Sci 68 1457-1469.
32. R Fricker, C Hesse, J Weiss, et al. (2004) Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation. Br I Clin Pharmacol 58 169-177.
33. C Aalkjaer and MJ Mulvany (1979) Morphological and mechanical properties of small mesenteric arteries and veins in spontaneously hypertensive rats. Acta Physiol Scand 107 309-312.
34. TL Smith and PM Hutchins (1979) Central hemodynamics in the developmental stage of spontaneous hypertension in the unanesthetized rat. Hypertension 1 508-517.
35. P Lund-Johansen (1994) Hemodynamics of essential hypertension. JD Swales (Ed.) Textbook of Hypertension Oxford: Blackwell Scientific Publications 61.
36. GD Fink, SW Watts and JJ Galligan (2002) Venoconstriction in the development of DOCA-salt hypertension. [Abstract]. Hypertension 40 418.
37. DS Martin, MC Rodrigo and CW Appelt (1998) Venous tone in the developmental stages of spontaneous hypertension. Hypertension 31 139-144.
38. WJ Willems, DR Harder, SJ Contney, et al. (1982) Sympathetic supraspinal control of venous membrane potential in spontaneous hypertension in vivo. Am I Physiol 243(3), C1016.
39. JA Walsh, C Hyman and RF Maronde (1969) Venous distensibility in essential hypertension. Cardiovasc Res 3 338-349.
40. ME Safar and DM London (1985) Venous system in essential hypertension. Clin Sci 69 497-504.
41. ME Safar and GM London (1987) Arterial and venous compliance in sustained essential hypertension. Hypertension 10 133-139.
42. S Julius (1988) Interaction between renin and the autonomic nervous system in hypertension. Am Heart I 116 611-616.
43. AV Benjafield, CL Jeyasingam, DR Nyholt, et al. (1998) G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 32 1094-1097.
44. RR Wenzel, W Siffert, H Bruck, et al. (2002) Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics 12 489-495.
45. A Mitchell, S Buhrmann, A Seifert, et al. (2003) Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein beta3 subunit gene (GNB3). Clin Pharmacol Ther 74 499-504.
46. A Mitchell, B Luckebergfeld, S Buhrmann, et al. (2004) Effects of systemic endothelin A receptor antagonism in various vascular beds in men: In vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism. Clin Pharmacol Ther 76. 396